114 related articles for article (PubMed ID: 10565308)
1. Partial monosomy 2p as the single chromosomal anomaly in a case of renal metanephric adenoma.
Stumm M; Koch A; Wieacker PF; Phillip C; Steinbach F; Allhoff EP; Buhtz P; Walter H; Tönnies H; Wirth J
Cancer Genet Cytogenet; 1999 Nov; 115(1):82-5. PubMed ID: 10565308
[No Abstract] [Full Text] [Related]
2. Metanephric adenoma lacks the gains of chromosomes 7 and 17 and loss of Y that are typical of papillary renal cell carcinoma and papillary adenoma.
Brunelli M; Eble JN; Zhang S; Martignoni G; Cheng L
Mod Pathol; 2003 Oct; 16(10):1060-3. PubMed ID: 14559991
[TBL] [Abstract][Full Text] [Related]
3. Renal cortical tumors. Cytogenetic characterization.
Dal Cin P; Gaeta J; Huben R; Li FP; Prout GR; Sandberg AA
Am J Clin Pathol; 1989 Oct; 92(4):408-14. PubMed ID: 2801608
[TBL] [Abstract][Full Text] [Related]
4. A renal metanephric adenoma showing both a 2p16e24 deletion and BRAF V600E mutation: a synergistic role for a tumor suppressor gene on chromosome 2p and BRAF activation?
Dadone B; Ambrosetti D; Carpentier X; Duranton-Tanneur V; Burel-Vandenbos F; Amiel J; Pedeutour F
Cancer Genet; 2013; 206(9-10):347-52. PubMed ID: 24432405
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous chromosome 7 and 17 gain and sex chromosome loss provide evidence that renal metanephric adenoma is related to papillary renal cell carcinoma.
Brown JA; Anderl KL; Borell TJ; Qian J; Bostwick DG; Jenkins RB
J Urol; 1997 Aug; 158(2):370-4. PubMed ID: 9224305
[TBL] [Abstract][Full Text] [Related]
6. Metaphase analysis of metanephric adenoma reveals chromosome Y loss with chromosome 7 and 17 gain.
Brown JA; Sebo TJ; Segura JW
Urology; 1996 Sep; 48(3):473-5. PubMed ID: 8804507
[TBL] [Abstract][Full Text] [Related]
7. Mapping a tumor suppressor gene to chromosome 2p13 in metanephric adenoma by microsatellite allelotyping.
Pesti T; Sükösd F; Jones EC; Kovacs G
Hum Pathol; 2001 Jan; 32(1):101-4. PubMed ID: 11172302
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetic analysis of six renal oncocytomas and a chromophobe cell renal carcinoma. Evidence that -Y, -1 may be a characteristic anomaly in renal oncocytomas.
Crotty TB; Lawrence KM; Moertel CA; Bartelt DH; Batts KP; Dewald GW; Farrow GM; Jenkins RB
Cancer Genet Cytogenet; 1992 Jul; 61(1):61-6. PubMed ID: 1638482
[TBL] [Abstract][Full Text] [Related]
9. Renal metanephric adenoma with previously unreported cytogenetic abnormalities: case report and review of the literature.
Rakheja D; Lian F; Tomlinson GE; Ewalt DH; Schultz RA; Margraf LR
Pediatr Dev Pathol; 2005; 8(2):218-23. PubMed ID: 15747102
[TBL] [Abstract][Full Text] [Related]
10. Metanephric adenoma during pregnancy: clinical presentation, histology, and cytogenetics.
Lerut E; Roskams T; Joniau S; Oyen R; Achten R; Van Poppel H; Debiec-Rychter M
Hum Pathol; 2006 Sep; 37(9):1227-32. PubMed ID: 16938529
[TBL] [Abstract][Full Text] [Related]
11. del(3p)(p13p21) in renal cell adenoma and del(4p)(p14) in bilateral renal cell carcinoma in two unrelated patients with von Hippel-Lindau disease.
Bergerheim US; Frisk B; Stellan B; Collins VP; Zech L
Cancer Genet Cytogenet; 1990 Oct; 49(1):125-31. PubMed ID: 2397466
[TBL] [Abstract][Full Text] [Related]
12. Detection of chromosome copy number alterations in metanephric adenomas by array comparative genomic hybridization.
Pan CC; Epstein JI
Mod Pathol; 2010 Dec; 23(12):1634-40. PubMed ID: 20802469
[TBL] [Abstract][Full Text] [Related]
13. A novel cytogenetic and molecular characterization of renal metanephric adenoma: Identification of partner genes involved in translocation t(9;15)(p24;q24).
Catic A; Kurtovic-Kozaric A; Johnson SH; Vasmatzis G; Pins MR; Kogan J
Cancer Genet; 2017 Aug; 214-215():9-15. PubMed ID: 28595733
[TBL] [Abstract][Full Text] [Related]
14. Gains of chromosomes 7, 17, 12, 16, and 20 and loss of Y occur early in the evolution of papillary renal cell neoplasia: a fluorescent in situ hybridization study.
Brunelli M; Eble JN; Zhang S; Martignoni G; Cheng L
Mod Pathol; 2003 Oct; 16(10):1053-9. PubMed ID: 14559990
[TBL] [Abstract][Full Text] [Related]
15. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
[TBL] [Abstract][Full Text] [Related]
16. Early and rapid prenatal diagnosis of monosomy 2q36.1 in trophoblast cells.
Tachdjian G; Aboura A; Brisset S; Dommergues M; Gajdos V; Labrune P
Fetal Diagn Ther; 2006; 21(5):428-32. PubMed ID: 16912492
[TBL] [Abstract][Full Text] [Related]
17. BRAF mutations in pediatric metanephric tumors.
Chami R; Yin M; Marrano P; Teerapakpinyo C; Shuangshoti S; Thorner PS
Hum Pathol; 2015 Aug; 46(8):1153-61. PubMed ID: 26014474
[TBL] [Abstract][Full Text] [Related]
18. Chromosomal changes in renal oncocytomas. Evidence that t(5;11)(q35;q13) may characterize a second subgroup of oncocytomas.
van den Berg E; Dijkhuizen T; Störkel S; de la Rivière GB; Dam A; Mensink HJ; Oosterhuis JW; de Jong B
Cancer Genet Cytogenet; 1995 Feb; 79(2):164-8. PubMed ID: 7889513
[TBL] [Abstract][Full Text] [Related]
19. A case of ring chromosome 2 with growth retardation, mild dysmorphism, and microdeletion of 2p detected using FISH.
Dee SL; Clark AT; Willatt LR; Yates JR
J Med Genet; 2001 Sep; 38(9):E32. PubMed ID: 11546833
[No Abstract] [Full Text] [Related]
20. Review of metanephric adenoma of the kidney with focus on clinical and pathobiological aspects.
Kuroda N; Tol M; Hiroi M; Enzan H
Histol Histopathol; 2003 Jan; 18(1):253-7. PubMed ID: 12507304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
